PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 87 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $791,000 | -95.5% | 100,000 | -86.6% | 0.07% | -95.1% |
| Q1 2022 | $17,699,000 | -33.9% | 747,441 | -4.5% | 1.34% | -14.1% |
| Q4 2021 | $26,774,000 | +407.6% | 782,857 | +163.0% | 1.56% | +401.3% |
| Q3 2021 | $5,275,000 | -73.8% | 297,709 | -33.7% | 0.31% | -73.1% |
| Q2 2021 | $20,155,000 | +18.8% | 449,082 | -31.4% | 1.16% | +13.9% |
| Q1 2021 | $16,962,000 | +142.5% | 654,900 | +83.1% | 1.02% | +96.5% |
| Q3 2020 | $6,994,000 | +21.5% | 357,769 | +9.7% | 0.52% | +43.0% |
| Q2 2020 | $5,758,000 | – | 326,064 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |